{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:39:58Z","timestamp":1787071198087,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study was designed and performed to investigate the relationship between fetal chromosome aberrations and screening markers in the first trimester of pregnancy in order to prevent the birth of infants with chromosome aberrations with early prenatal diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted an analytic cross-sectional study on result of chromosomal culture of 762 pregnant women with high-risk combined screening test from December 2018 to June 2020 and analyzed by SPSS program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There was a significant relationship between chromosome structural abnormalities with free beta-human chorionic gonadotropin (free \u03b2-hCG) values equal to and higher than 1.5 multiples of the median (MoM) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      : 0.05). The highest incidence of disorder in number of chromosomes with abnormal nuchal translucency (NT) percentiles (\u226599%) was seen (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). It also shows that the cumulative number of chromosome aberrations of 25 (78.12%) occurred in individuals with a NT less than 99\n                      <jats:sup>th<\/jats:sup>\n                      percentile and at the same time a risk of 1\/50\u2264 risk &lt;1\/10.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>According to the results, Comparative Genomic Hybridization (CGH) array method is recommended to detect structural abnormalities in chromosomes in samples with NT \u22653.5. In addition, it is noteworthy that chromosomal structural abnormalities occur in free \u03b2-hCG \u22651.5 MoM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Due to the frequency of chromosomal structural disorders and its effect on the incidence of fetal abnormalities, the study of chromosomal structural disorders is recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpvm.ijpvm_572_20","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T09:07:10Z","timestamp":1716973630000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Relationship between Screening Markers in the First Trimester of Pregnancy and Chromosome Aberrations"],"prefix":"10.4103","volume":"13","author":[{"given":"Maryam","family":"Mirsafaie","sequence":"first","affiliation":[{"name":"Department of Midwifery and Reproductive Health, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Moghaddam-Banaem","sequence":"additional","affiliation":[{"name":"Department of Midwifery and Reproductive Health, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Kheirollahi","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Biology, School of Medicine, Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"R1-20250813","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/uog.8808","article-title":"Early fetal growth, PAPP-A and free \u03b2-hCG in relation to risk of delivering a small-for-gestational age infant","volume":"37","author":"Kirkegaard","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R2-20250813","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12291-012-0269-9","article-title":"First trimester maternal serum screening using biochemical markers PAPP-A and free \u03b2-hCG for down syndrome, patau syndrome and edward syndrome","volume":"28","author":"Shiefa","year":"2013","journal-title":"Indian J Clin Biochem"},{"key":"R4-20250813","first-page":"35","article-title":"Chromosomal abnormalities-a review","volume":"4","author":"Khandekar","year":"2013","journal-title":"Central India J Dent Sci"},{"key":"R5-20250813","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5603\/GP.2019.0029","article-title":"The clinical usefulness of biochemical (free \u03b2-hCG, PAPP-A) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy","volume":"90","author":"Ziolkowska","year":"2019","journal-title":"Ginekol Pol"},{"key":"R6-20250813","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.semperi.2015.11.006","article-title":"Screening for fetal aneuploidy","volume":"40","author":"Rink","year":"2016","journal-title":"Semin Perinatol"},{"key":"R7-20250813","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pd.2730","article-title":", Aneuploidy screening: a position statement from a committee on behalfof the Board of the International Society for Prenatal Diagnosis, January 2011","volume":"31","author":"Benn","year":"2011","journal-title":"Prenat Diagn"},{"key":"R8-20250813","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/pd.407","article-title":"Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome","volume":"22","author":"Yaron","year":"2002","journal-title":"Prenat Diagn"},{"key":"R9-20250813","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s13224-013-0481-4","article-title":"Variation of papp-a level in the first trimester of pregnancy and its clinical outcome","volume":"64","author":"Patil","year":"2014","journal-title":"J Obstet Gynecol India"},{"key":"R10-20250813","first-page":"36","article-title":"High maternal serum free beta-hCG levels in Down syndrome pregnancies: A preliminary report","volume":"19","author":"Hsu","year":"1996","journal-title":"Changgeng Yi Xue Za Zhi"},{"key":"R11-20250813","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/pd.898","article-title":"First-trimester nuchal translucency and maternal serum free \u03b2-hCG and PAPP-A can detect triploidy and determine the parental origin","volume":"24","author":"Yaron","year":"2004","journal-title":"Prenat Diagn"},{"key":"R12-20250813","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/uog.14880","article-title":"Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: A systematic review and meta-analysis","volume":"46","author":"Grande","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R13-20250813","first-page":"420","article-title":"Indications for genetic amniocentesis investigated at the Department of Gynecology, Obstetrics, and Oncologic Gynecology, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz","volume":"85","author":"Sad\u0142ecki","year":"2014","journal-title":"Ginekol Pol"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_572_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:42:58Z","timestamp":1787067778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_572_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_572_20","relation":{},"ISSN":["2008-7802","2008-8213"],"issn-type":[{"value":"2008-7802","type":"print"},{"value":"2008-8213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2020-09-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}